Progress at the Lab Bench Doesn’t Equal Profits
The last 8 years for Bioniche Life Sciences Inc., BNC TSX, has really required an active trading strategy to capture what value was available at certain times. It hasn’t been a buy and hold stock.
September 17, 2008 | Posted in Biotechnology | Read Article »
